Techniques in Cell Cycle Analysis

Nonfiction, Science & Nature, Science, Biological Sciences, Cytology, Other Sciences, Molecular Biology
Cover of the book Techniques in Cell Cycle Analysis by Joe W. Gray, Zbigniew Darzynkiewicz, Humana Press
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: Joe W. Gray, Zbigniew Darzynkiewicz ISBN: 9781603274067
Publisher: Humana Press Publication: February 24, 2008
Imprint: Humana Language: English
Author: Joe W. Gray, Zbigniew Darzynkiewicz
ISBN: 9781603274067
Publisher: Humana Press
Publication: February 24, 2008
Imprint: Humana
Language: English

Quantification of the proliferative characteristics of normal and malignant cells has been of interest to oncolo­ gists and cancer biologists for almost three decades. This interest stems from (a) the fact that cancer is a disease of uncontrolled proliferation, (b) the finding that many of the commonly used anticancer agents are preferentially toxic to cells that are actively proliferating, and (c) the observa­ tion that significant differences in proliferation characteristics exist between normal and malignant cells. Initially, cell cycle analysis was pursued enthusiastically in the hope of gener­ ating information useful for the development of rational cancer therapy strategies; for example, by allowing identi­ fication of rapidly proliferating tumors against which cell cycle-specific agents could be used with maximum effec­ tiveness and by allowing rational scheduling of cell cyc- specific therapeutic agents to maximize the therapeutic ratio. Unfortunately, several difficulties have prevented realiza­ tion of the early promise of cell cycle analysis: Proliferative patterns of the normal and malignant tissues have been found to be substantially more complex than originally an­ ticipated, and synchronization of human tumors has proved remarkably difficult. Human tumors of the same type have proved highly variable, and the cytokinetic tools available for cell cycle analysis have been labor intensive, as well as somewhat subjective and in many cases inapplicable to humans. However, the potential for substantially improved cancer therapy remains if more accurate cytokinetic infor­ mation about human malignancies and normal tissues can be obtained in a timely fashion.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Quantification of the proliferative characteristics of normal and malignant cells has been of interest to oncolo­ gists and cancer biologists for almost three decades. This interest stems from (a) the fact that cancer is a disease of uncontrolled proliferation, (b) the finding that many of the commonly used anticancer agents are preferentially toxic to cells that are actively proliferating, and (c) the observa­ tion that significant differences in proliferation characteristics exist between normal and malignant cells. Initially, cell cycle analysis was pursued enthusiastically in the hope of gener­ ating information useful for the development of rational cancer therapy strategies; for example, by allowing identi­ fication of rapidly proliferating tumors against which cell cycle-specific agents could be used with maximum effec­ tiveness and by allowing rational scheduling of cell cyc- specific therapeutic agents to maximize the therapeutic ratio. Unfortunately, several difficulties have prevented realiza­ tion of the early promise of cell cycle analysis: Proliferative patterns of the normal and malignant tissues have been found to be substantially more complex than originally an­ ticipated, and synchronization of human tumors has proved remarkably difficult. Human tumors of the same type have proved highly variable, and the cytokinetic tools available for cell cycle analysis have been labor intensive, as well as somewhat subjective and in many cases inapplicable to humans. However, the potential for substantially improved cancer therapy remains if more accurate cytokinetic infor­ mation about human malignancies and normal tissues can be obtained in a timely fashion.

More books from Humana Press

Cover of the book Enzymatic Analysis by Joe W. Gray, Zbigniew Darzynkiewicz
Cover of the book Myasthenia Gravis and Related Disorders by Joe W. Gray, Zbigniew Darzynkiewicz
Cover of the book The Proteomics Protocols Handbook by Joe W. Gray, Zbigniew Darzynkiewicz
Cover of the book Cytokine Knockouts by Joe W. Gray, Zbigniew Darzynkiewicz
Cover of the book mTOR Pathway and mTOR Inhibitors in Cancer Therapy by Joe W. Gray, Zbigniew Darzynkiewicz
Cover of the book Drug Abuse Treatment by Joe W. Gray, Zbigniew Darzynkiewicz
Cover of the book Alcohol, Cocaine, and Accidents by Joe W. Gray, Zbigniew Darzynkiewicz
Cover of the book Clinical Neuroimmunology by Joe W. Gray, Zbigniew Darzynkiewicz
Cover of the book Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy by Joe W. Gray, Zbigniew Darzynkiewicz
Cover of the book Vitamin D by Joe W. Gray, Zbigniew Darzynkiewicz
Cover of the book Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy by Joe W. Gray, Zbigniew Darzynkiewicz
Cover of the book Clinical Oral Medicine and Pathology by Joe W. Gray, Zbigniew Darzynkiewicz
Cover of the book Forensic Pathology Reviews by Joe W. Gray, Zbigniew Darzynkiewicz
Cover of the book Endoscopic Ultrasound by Joe W. Gray, Zbigniew Darzynkiewicz
Cover of the book The Centrosome by Joe W. Gray, Zbigniew Darzynkiewicz
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy